Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.230
+0.040 (1.83%)
At close: Jan 17, 2025, 4:00 PM
2.200
-0.030 (-1.35%)
After-hours: Jan 17, 2025, 7:50 PM EST
OTLK's stock price has decreased by -70.99% in the past year and price targets may not have had time to catch up.
Outlook Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$23.08
Upside
+934.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +438.12% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | Jan 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 2, 2024 |
| BTIG | BTIG | Strong Buy Maintains $50 → $9 | Strong Buy | Maintains | $50 → $9 | +303.59% | Nov 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | Nov 29, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +2,142.15% | Oct 18, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +1,379.82% | Sep 3, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $53 | Strong Buy | Maintains | $53 | +2,276.68% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | May 17, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +2,142.15% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +1,245.29% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +2,590.58% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +1,693.72% | Jan 25, 2024 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $31 | Hold → Strong Buy | Upgrades | $31 | +1,308.07% | Jan 25, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $30 → $40 | Strong Buy | Maintains | $30 → $40 | +1,693.72% | Dec 29, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.